220 related articles for article (PubMed ID: 30578953)
1. Impact of subjective vs. objective remission status on subjective cognitive impairments in depression.
Sawada K; Yoshida K; Ozawa C; Mizuno Y; Rubinstein EB; Suzuki T; Mimura M; Uchida H
J Affect Disord; 2019 Mar; 246():99-104. PubMed ID: 30578953
[TBL] [Abstract][Full Text] [Related]
2. Guidance on the conversion of the Chinese versions of the Quick Inventory of Depressive Symptomatology-Self-Report (C-QIDS-SR) and the Montgomery-Asberg Scale (C-MADRS) in Chinese patients with major depression.
Liu J; Xiang YT; Lei H; Wang Q; Wang G; Ungvari GS; Morris DW; Zhu XZ; Lai KY; Zhong BL; Wong SY; Zhang L; Zhang Q; Zou YC; Xiao L; Zhao Q; Li Y; Wu J; Zhang GF; Chiu HF
J Affect Disord; 2014 Jan; 152-154():530-3. PubMed ID: 24144585
[TBL] [Abstract][Full Text] [Related]
3. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
[TBL] [Abstract][Full Text] [Related]
4. Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS.
Carmody TJ; Rush AJ; Bernstein IH; Brannan S; Husain MM; Trivedi MH
J Affect Disord; 2006 Oct; 95(1-3):115-8. PubMed ID: 16707162
[TBL] [Abstract][Full Text] [Related]
5. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
Zimmerman M; Posternak MA; Chelminski I
J Psychiatr Res; 2004; 38(6):577-82. PubMed ID: 15458853
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
7. Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials.
Kornstein S; Chang CT; Gommoll CP; Edwards J
Int Clin Psychopharmacol; 2018 Jul; 33(4):217-223. PubMed ID: 29608461
[TBL] [Abstract][Full Text] [Related]
8. Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross-sectional analysis of baseline data from PERFORM-J.
Sumiyoshi T; Watanabe K; Noto S; Sakamoto S; Moriguchi Y; Tan KHX; Hammer-Helmich L; Fernandez J
J Affect Disord; 2019 Nov; 258():172-178. PubMed ID: 31426015
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
McIntyre RS; Florea I; Tonnoir B; Loft H; Lam RW; Christensen MC
J Clin Psychiatry; 2017 Jan; 78(1):115-121. PubMed ID: 27780334
[TBL] [Abstract][Full Text] [Related]
10. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
[TBL] [Abstract][Full Text] [Related]
11. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
Am J Psychiatry; 2019 May; 176(5):358-366. PubMed ID: 30922100
[TBL] [Abstract][Full Text] [Related]
12. Defining remission on the Montgomery-Asberg depression rating scale.
Zimmerman M; Posternak MA; Chelminski I
J Clin Psychiatry; 2004 Feb; 65(2):163-8. PubMed ID: 15003068
[TBL] [Abstract][Full Text] [Related]
13. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
Rush AJ; Trivedi MH; Ibrahim HM; Carmody TJ; Arnow B; Klein DN; Markowitz JC; Ninan PT; Kornstein S; Manber R; Thase ME; Kocsis JH; Keller MB
Biol Psychiatry; 2003 Sep; 54(5):573-83. PubMed ID: 12946886
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample.
Bernstein IH; Rush AJ; Stegman D; Macleod L; Witte B; Trivedi MH
CNS Spectr; 2010 Jul; 15(7):458-68. PubMed ID: 20625366
[TBL] [Abstract][Full Text] [Related]
15. Relationship between childhood physical abuse and clinical severity of treatment-resistant depression in a geriatric population.
Yrondi A; Arbus C; Bennabi D; D'Amato T; Bellivier F; Bougerol T; Camus V; Courtet P; Doumy O; Genty JB; Holtzmann J; Horn M; Lancon C; Leboyer M; Llorca PM; Maruani J; Moirand R; Molière F; Petrucci J; Richieri R; Samalin L; Stephan F; Vaiva G; Walter M; ; Haffen E; Aouizerate B; El-Hage W
PLoS One; 2021; 16(4):e0250148. PubMed ID: 33878137
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
17. The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.
Fantino B; Moore N
BMC Psychiatry; 2009 May; 9():26. PubMed ID: 19473506
[TBL] [Abstract][Full Text] [Related]
18. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS-C16 and QIDS-SR16) in the elderly.
Doraiswamy PM; Bernstein IH; Rush AJ; Kyutoku Y; Carmody TJ; Macleod L; Venkatraman S; Burks M; Stegman D; Witte B; Trivedi MH
Acta Psychiatr Scand; 2010 Sep; 122(3):226-34. PubMed ID: 20085556
[TBL] [Abstract][Full Text] [Related]
20. Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.
Freeman MP; Fava M; Gommoll C; Chen C; Greenberg WM; Ruth A
Int Clin Psychopharmacol; 2016 Mar; 31(2):100-9. PubMed ID: 26584326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
